PHARMERICA

CLINICAL ALERT

The U.S. is experiencing an interruption in the dependable availability of oseltamivir oral suspension and capsules – a neuraminidase inhibitor antiviral agent used for prophylaxis and treatment of influenza. This supply disruption may affect all available NDCs of oseltamivir, with variable anticipated dates of market availability. The FDA does not yet note a widespread drug shortage; rather, acutely high demand is overwhelming supply from primary manufacturers.
Additional information in the PharMerica memo below.

PharMerica Memo

Delivering Value Beyond Medication

World-class pharmacy services. That’s what PharMerica delivers to our partners in a broad array of healthcare markets, including long-term care, senior living, hospice, IDD/behavioral health, home infusion, specialty, and hospital management.

PharMerica is a national leader in pharmacy services with a local touch, serving:

• 30-plus years of senior care experience
• Over 3,100 facilities throughout the country
• Over 140 pharmacies
• Over 6,000 dedicated healthcare professionals

At each touchpoint, we’re furthering our mission: to help people live their best life.

We’re also advancing the success of our clients, providing the capabilities and trusted expertise to help facilities stay ahead. As a total pharmacy solution, our long-term care services ensure accurate and timely access to medications, control pharmacy costs, and foster compliance with regulations with a best-in-class approach.